The PE Ratio as of November 2024 (TTM) for SciSparc Ltd. (SPRC) is -0.02

According to SciSparc Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -61.80% compared to the average of -0.05 of the last 4 quarters.

SciSparc Ltd. (SPRC) Historical PE Ratio (quarterly & annually)

How has SPRC PE Ratio performed in the past?

The mean historical PE Ratio of SciSparc Ltd. over the last ten years is -681.34. The current -0.02 PE Ratio has changed -99.71% with respect to the historical average. Over the past ten years (40 quarters), SPRC's PE Ratio was at its highest in in the December 2022 quarter at 0.36. The PE Ratio was at its lowest in in the June 2016 quarter at -1975.37.

SciSparc Ltd. (SPRC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of SciSparc Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SciSparc Ltd. (SPRC) Average PE Ratio

How has SPRC PE Ratio performed in the past?

The current PE Ratio of SciSparc Ltd. (SPRC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SciSparc Ltd. (SPRC) PE Ratio vs. Peers

How is SPRC’s PE Ratio compared to its peers?

SciSparc Ltd.’s PE Ratio is greater than OncoSec Medical Incorporated (-0.05), greater than Virax Biolabs Group Limited (-0.68), less than Hillstream BioPharma, Inc. (-0.00), greater than ZyVersa Therapeutics, Inc. (-0.07), greater than Unicycive Therapeutics, Inc. (-0.62), greater than Quoin Pharmaceuticals, Ltd. (-0.44), greater than Cardio Diagnostics Holdings, Inc. (-0.72), greater than PaxMedica, Inc. Common Stock (-0.05), greater than YS Biopharma Co., Ltd. (-2.21), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.44), greater than Virios Therapeutics, Inc. (-0.76), greater than Hoth Therapeutics, Inc. (-0.82), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (7.73), greater than Assembly Biosciences, Inc. (-2.10), greater than Instil Bio, Inc. (-1.50), greater than Nuvation Bio Inc. (-1.10), greater than Blue Water Vaccines, Inc. (-0.17), greater than Revelation Biosciences, Inc. (-0.09), less than Kiora Pharmaceuticals, Inc. (4.79),

Build a custom stock screener for SciSparc Ltd. (SPRC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SciSparc Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SciSparc Ltd. (SPRC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SciSparc Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.